IL17A and rheumatoid arthritis: IL-17 not only induces proinflammatory cytokines, but also directly enhances osteoclastogenesis by upregulating receptor activator nuclear kappa ligand (RANKL) on osteoblasts [5], contributing to bone erosion in RA.